SSB
SGMO

Sandy Spring Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Sandy Spring Bank’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$263 Hold
400
– – ﹤0.01% 1151
2024
Q4 		$408 Hold
400
– – ﹤0.01% 1138
2024
Q3 		$347 Hold
400
– – ﹤0.01% 1136
2024
Q2 		$144 Buy
+400
New +$216 ﹤0.01% 1238

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sandy Spring Bank's SGMO Position: Q1 2025 in Review

Sandy Spring Bank held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q1 2025 at 400 shares worth $263. The position accounts for ﹤0.01% of the portfolio, ranked #1151.

Sandy Spring Bank first reported a position in SGMO in Q2 2024 and has held it in 4 quarters since. The position peaked at $408 in Q4 2024. 122 funds tracked by Wall St. Rank hold SGMO as of Q1 2025.

  • Sandy Spring Bank held 400 shares of SANGAMO THERAPEUTICS INC worth $263 as of Q1 2025.
  • Sandy Spring Bank left its SANGAMO THERAPEUTICS INC share count unchanged in Q1 2025.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #1151 holding.
  • Sandy Spring Bank first reported a position in SANGAMO THERAPEUTICS INC in Q2 2024 and has held it in 4 quarters since.
  • Sandy Spring Bank's SANGAMO THERAPEUTICS INC position peaked at $408 in Q4 2024.
  • 122 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.